Insulin Lispro (Humalog) injectable
Form: Vials/pens
Strength: U-100, U-200
Reference Brands: Humalog, Admelog, Fiasp(US); Humalog, Fiasp(EU)
Category: Diabetes
Insulin Lispro (Humalog) is a rapid-acting insulin approved in the EU and US for post-meal blood glucose control. In the EU, Novo Nordisk’s Fiasp, a faster-acting version, is regulated by EMA with dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, the FDA has approved Humalog and biosimilars like Admelog based on comprehensive clinical data, biosimilarity, and ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for approval and post-marketing safety monitoring. For expert assistance with pharmaceutical dossiers and compliance, visit PharmaTradz, your trusted partner in regulatory solutions.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Premixed Insulins (70/30, 50/50) Injectable
Strength: U-100
Form: Vials, pens
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
View Details Get Enquiry
Insulin Aspart (Novolog) injectable
Strength: U-100, U-200
Form: Vials/pens
Reference Brands: Novolog, Fiasp(US &EU)
View Details Get Enquiry
Insulin Glargine (Lantus) injectable
Strength: U-100, U-300
Form: Vials/pens
Reference Brands: Lantus, Basaglar, Toujeo(US); Lantus, Toujeo(EU)
View Details Get Enquiry
Regular Insulin (Human) Injectable
Strength: U-100 (100 units/mL)
Form: Vials/pens
Reference Brands: Humulin R, Novolin R, Admelog R(US); Actrapid, Humulin R, Monotard R(EU)
View Details Get Enquiry